(R)-5-(chloromethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one CAS NO.496031-57-3

The product is the key intermediate  for producing the Linezolid and we have produced it for several times above 50kg  per batch with high quality of above 99% purity. At the same time, the related impurities have been studied in detail, for example, the chiral isomer<0.15%, single known impurity<0.15%, single unknown impurity<0.1%.

For the market, the complete CMC file of it can be provide, for example, COA, ROS, simple procedure and etc. The following three points are characteristics of it.

1, high purity

2, produce the key intermediate in big scale

3, can control it with the very low chiral impurity (<0.15%)

BioBond (Shanghai) Pharmaceutical Co. Ltd (shorten as “BioBond”) has been Founded by some famous professors from Shanghai Institute of Materia and Medica, CAS to Develop new drug in nervous drug and antitumor areas, Located in Shanghai Zhangjiang Hi-tech Park, Eastern Areas ( named as National Medical Apparatus Park).

BioBond has an excellent team with rich experiences in development of drug including drug synthesis, pharmacology, drug formulation, drug analysis scientists. There are two professors and four Doctors and a lot of masters in BioBond. It has three main business domains:

1, Supply some key intermediates of API for some pharmaceutical company in the API’s GMP system;

2, Serve big pharmaceutical company in China for Pre-clinical research of APIs and overall solutions;

3, Develop new drug including designing and synthesizing new compounds and then testing activity.